20250177365. Treatment Migrain (Allergan Pharmaceuticals International Limited)
TREATMENT OF MIGRAINE
Abstract: the present disclosure provides methods for the acute treatment of migraine with or without aura, comprising the administration of ubrogepant. in particular, the present disclosure provides methods for the acute treatment of migraine in patients having hepatic impairment; in patients with renal impairment; and in patients concurrently taking cyp3a4 modulators or bcrp and/or p-gp only inhibitors.
Inventor(s): Joel M. Trugman, Ramesh Boinpally, Abhijeet Jakate, Michelle Finnegan, Mary Ann Johnson, Leonardo R. Allain, W. Mark Eickhoff, Craig B. Ikeda, Chad D. Brown, Francis J. Flanagan, Rebecca Nofsinger, Melanie Marota, Lisa Lupton, Paresh B. Patel, Hanmi Xi, Wei Xu
CPC Classification: A61K31/4375 (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms ; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles ; soap compositions ))
Search for rejections for patent application number 20250177365
- Patent Applications
- Allergan Pharmaceuticals International Limited
- CPC A61K31/4375
- Joel M. Trugman of Hoboken NJ US
- Ramesh Boinpally of Princeton NJ US
- Abhijeet Jakate of Edison NJ US
- Michelle Finnegan of Madison NJ US
- Mary Ann Johnson of Norristown PA US
- Leonardo R. Allain of Lansdale PA US
- W. Mark Eickhoff of Lansdale PA US
- Craig B. Ikeda of Harleysville PA US
- Chad D. Brown of Quakertown PA US
- Francis J. Flanagan of North Wales PA US
- Rebecca Nofsinger of Lansdale PA US
- Melanie Marota of Mount Laurel NJ US
- Lisa Lupton of South San Francisco CA US
- Paresh B. Patel of Langhome PA US
- Hanmi Xi of Furlong PA US
- Wei Xu of West Point PA US